CADASIL Registry Study

Recruiting now

Conditions studied: Cadasil

In brief

The aim of this study is to determine the clinical spectrum and natural progression of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and related disorders in a prospective multicenter study, to assess the clinical, genetic and epigenetic features of patients with CADASIL , to optimize clinical management.

Key facts

Study ID

NCT04310098

Run by

Bin Cai

People needed

1000

Starts

2020-03-09

Expected to finish

2049-03-09

Last updated by the study team

2023-09-28

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Sign informed consent.
• Age>18
• Clinical diagnosis of patients with CADASIL,and confirmed by genetic test or skin biopsy
• Asymptomatic NOTCH3 mutation carriers
• Relatives of CADASIL patients or carriers
• Unrelated healthy controls

You may not qualify if…

• Unable to cooperate with inspectors
• Serious systemic illness, such as heart, liver, kidney disease or major mental illness
• Contraindications for imaging examination

Where it is running

• Department of Neurology , First Affiliated Hospital Fujian Medical University — Fuzhou, Fujian, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.